Danijela Simonovic

Danijela Simonovic

Auto-generated profile, based on publicly available information

Danijela Simonovic

Department of Pharmacy, Faculty of Health Sciences UiT the Arctic University of Norway Tromsø Norway

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IHIda Kristine Østnes Hansen
Ida Kristine Østnes Hansen
TLTomas Lövdahl
Tomas Lövdahl
DSDanijela Simonovic
Danijela Simonovic
KHKine Østnes Hansen
Kine Østnes Hansen
AAAaron J. C. Andersen
Aaron J. C. Andersen
THTor Haug
Tor Haug
Turgencin A, a potent antimicrobial peptide isolated from the Arctic sea squirt Synoicum turgens, consists of 36 amino acid residues and three disulfide bridges, making it challenging to synthesize. The aim of the present study was to develop a truncated peptide with an antimicrobial drug lead potential based on turgencin A. The experiments consisted of: (1) sequence analysis and prediction of antimicrobial potential of truncated 10-mer sequences; (2) synthesis and antimicrobial screening of a lead peptide devoid of the cysteine residues; (3) optimization of in vitro antimicrobial activity of the lead peptide using an amino acid replacement strategy; and (4) screening the synthesized peptides for cytotoxic activities. In silico analysis of turgencin A using various prediction software indicated an internal, cationic 10-mer sequence to be putatively antimicrobial. The synthesized truncated lead peptide displayed weak antimicrobial activity. However, by following a systematic amino acid replacement strategy, a modified peptide was developed that retained the potency of the original peptide. The optimized peptide StAMP-9 displayed bactericidal activity, with minimal inhibitory concentrations of 7.8 µg/mL against Staphylococcus aureus and 3.9 µg/mL against Escherichia coli, and no cytotoxic effects against mammalian cells. Preliminary experiments indicate the bacterial membranes as immediate and primary targets.

Verified
Journal Article
Open access
PDF file
HDHymonti Dey
Hymonti Dey
DSDanijela Simonovic
Danijela Simonovic
IHIngrid Norberg-Schulz Hagen
Ingrid Norberg-Schulz Hagen
TVTerje Vasskog
Terje Vasskog
EFElizabeth G. Aarag Fredheim
Elizabeth G. Aarag Fredheim
THTor Haug
Tor Haug
We have synthesised short analogues of the marine antimicrobial peptide Turgencin A from the colonial Arctic ascidian Synoicum turgens. In this study, we focused on a central, cationic 12-residue Cys-Cys loop region within the sequence. Modified (tryptophan- and arginine-enriched) linear peptides were compared with Cys-Cys cyclic derivatives, and both linear and Cys-cyclic peptides were N-terminally acylated with octanoic acid (C8), decanoic acid (C10) or dodecanoic acid (C12). The highest antimicrobial potency was achieved by introducing dodecanoic acid to a cyclic Turgencin A analogue with low intrinsic hydrophobicity, and by introducing octanoic acid to a cyclic analogue displaying a higher intrinsic hydrophobicity. Among all tested synthetic Turgencin A lipopeptide analogues, the most promising candidates regarding both antimicrobial and haemolytic activity were C12-cTurg-1 and C8-cTurg-2. These optimized cyclic lipopeptides displayed minimum inhibitory concentrations of 4 µg/mL against Staphylococcus aureus, Escherichia coli and the fungus Rhodothorula sp. Mode of action studies on bacteria showed a rapid membrane disruption and bactericidal effect of the cyclic lipopeptides. Haemolytic activity against human erythrocytes was low, indicating favorable selective targeting of bacterial cells.

28 April 2025 in Journal of Peptide Science
Verified
Journal Article
Closed access
DSDanijela Simonovic
Danijela Simonovic
HDHymonti Dey
Hymonti Dey
NJNatascha Johansen
Natascha Johansen
TATrude Anderssen
Trude Anderssen
IHIda Kristine Østnes Hansen
Ida Kristine Østnes Hansen
MSMorten B. Strøm
Morten B. Strøm